[Patient with stomach cancer with metastases. What is the value of chemotherapy?].

Wilke, H; Stahl, M; Vanhoefer, U

[Patient with stomach cancer with metastases. What is the value of chemotherapy?]. / Magenkrebspatient mit Metastasen. Was leistet die Chemotherapie?

Wilke, H; Stahl, M; Vanhoefer, U.

Affiliation

Wilke H; Klinik für Innere Medizin I und Internistische Onkologie/Hämatologie, Kliniken Essen-Mitte. hwilke@kliniken-essen-mitte.de

MMW Fortschr Med ; 145(48): 39-42, 2003 Nov 27.

Article in De | MEDLINE | ID: mdl-14724998

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Stomach Neoplasms/drug therapy; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Fluorouracil/administration & dosage; Fluorouracil/adverse effects; Humans; Neoplasm Metastasis; Neoplasm Staging; Palliative Care; Quality of Life; Randomized Controlled Trials as Topic; Salvage Therapy; Stomach Neoplasms/mortality; Stomach Neoplasms/pathology; Survival Rate

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Stomach Neoplasms / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials Aspects: Patient_preference Limits: Humans Language: De Journal: MMW Fortschr Med Year: 2003 Document type: Article

Search on Google

XML

PubMed Links